Happy birthday, Dr. Leary
Timothy Leary was born 106 years ago today. He was a real psychologist who made a real contribution, a researcher who broke most of the rules I live by, the loudest voice of a movement that got psychedelic science banned for thirty years, and a man who was funny about all of it to the end. Here is the honest version: what I keep, and what I don't.
By Reid Robison, MD. 4,406 words, with a timeline, Leary's own personality circle to place yourself on, the Concord prison numbers before and after the audit, and a ledger you can weigh yourself.
I run psychedelic clinical trials for a living, inside a regulatory system that Timothy Leary did a great deal to provoke into existence. Every consent form I sign, every blinded rater, every session monitor with a bachelor's degree and a year of clinical experience, every line in the FDA's 2026 guidance on how these studies must be run, is in some sense a reply to him.1 So I have a complicated relationship with the man, and today is his birthday, and I would rather write the complicated version than either of the easy ones.
The easy versions are well rehearsed. In one he is the prophet who was right about everything and persecuted for it. In the other he is the clown who single-handedly got a promising medicine banned and set the field back a generation. Both are available at any psychedelic conference, usually within fifty feet of each other. Neither is honest. He was a working scientist for about a decade, then for three years a man running studies and a movement at the same time and losing track of which was which, then for thirty years a public figure who kept the word "science" but not the practice. Some of what he said in every period was true, and some of what he guessed in the middle period has since been proven.
- He was a serious psychologist first. His 1957 interpersonal circle is still in use; his 1955 paper on psychotherapy outcomes was an early, uncomfortable piece of honesty about the profession.23
- At Harvard he asked the right questions, and his methods could not answer them. Set and setting, the therapeutic frame, psilocybin for prisoners and for divinity students: all of it anticipated the modern field, and some of it has since been confirmed in controlled trials. But the studies were open-label, the experimenters took the drug with the subjects by design, undergraduates got involved, and the headline result did not survive an audit.456
- Then the movement swallowed the research. "Turn on, tune in, drop out" was 1967. Prohibition was 1970. He was not the only cause, and he was not nothing.78
- His best idea was about consent. Two commandments: do not alter another person's consciousness without their consent, and do not stop them altering their own. I still think that is the right frame, and his own career violated the first half.9
- What I keep: set and setting, the person's own authority over their experience, the humor, the refusal to be afraid of dying. What I don't: the evangelism, the data, the people he cost, and the decades.
1A life, in order
It helps to see the whole arc before judging any part of it. Tap a year.101112
Seventy-five years
Pen-blue for the science, yellow for the counterculture, grey for the law and the later years. Tap a point.
Tap a year.
2The psychologist
Here is the part that gets left out of both easy versions. Leary was a respected clinical psychologist before anyone outside Mexico had heard of psilocybin, and one piece of his work is still in the textbooks for its own sake. In 1957 he published Interpersonal Diagnosis of Personality, which arranged the ways people relate to each other on a circle with two axes: dominance to submission running top to bottom, and hostility to warmth running left to right.2 Every interpersonal style is a point on the circle; styles next to each other blend; styles across from each other clash. It was clever, it was measurable, and the "interpersonal circumplex" that grew out of it is used in personality research and therapy to this day, usually without his name on it.13 Place yourself.
The Leary circle
Two sliders: how much you tend to lead versus follow, and how warm versus cool you run with people. The dot is you; the labels are the eight octants of the 1957 model, in modern wording. Nothing is saved.
Two years earlier he had co-written something braver. With Frank Barron he compared patients who received psychotherapy with patients on a waiting list and found, to the profession's discomfort, that the treated group had not improved more than the untreated one.3 It was a small study and the field has since done much better, but the instinct in it is the right one: measure the thing you believe in, and publish when it comes out wrong. Hold on to that instinct, because he lost it.
He also lost his wife. Marianne Leary died by suicide in 1955, on his thirty-fifth birthday, leaving him with two small children.11 I mention it not to explain what came later but because the people who write about Leary as a cartoon tend to skip the parts where he was a person.
3Harvard: the right questions, the wrong methods
In August 1960, on holiday in Cuernavaca, Leary ate psilocybin mushrooms by a swimming pool and came back to Harvard, where he had been a lecturer for a year, convinced he had found the most important tool in psychology.12 What followed, the Harvard Psilocybin Project, lasted about three years and contained, in embryo, most of what the modern field is now doing carefully: psilocybin given in a supportive setting, with preparation and a guide; psilocybin for people the system had given up on; psilocybin to test whether a chemical could produce a religious experience. He and his colleagues also articulated the idea that the drug's effect depends on the mindset of the person and the surroundings they take it in, and gave it the name everyone still uses, set and setting.14 That phrase alone is a contribution. Norman Zinberg made it rigorous twenty years later, but Leary made it a sentence.15
Now look at how the studies were done, and let me be careful here, because the easy version overstates this too. The Harvard studies were open-label: everyone knew what they were taking. That is not a sin. Open-label studies are how a field finds out what is worth testing; the modern psilocybin trials grew out of open-label pilots, and I run them myself. What open-label studies cannot do is prove that the drug caused the outcome, and the trouble at Harvard was that the results were reported as if they had. The flagship was the Concord Prison Experiment: 32 young inmates given psilocybin in group sessions. The researchers took the drug alongside them, which was not a lapse but a stated method, written into the paper: the aim was "to dispel the fear that often accompanies relationships between" experimenters and subjects.16 I understand the reasoning, and I think it was wrong, because a guide who is also tripping cannot watch the room, and because it made the results impossible to defend. The reported result was spectacular: where prison records predicted that most would be back inside within months of parole, only a quarter had returned. It was the first psychedelic outcome claim to reach the public, and it was wrong. When Rick Doblin tracked down the records thirty-four years later, he found that the Concord men had been compared against a base rate measured over a longer period than their own follow-up, and that returning to prison on a parole violation had been counted differently from returning for a new crime. Compared properly, the psilocybin group went back to prison at about the rate everyone else did.4 That does not prove psilocybin did nothing for those men; it proves the study could not tell. Here are the numbers both ways.
Concord, before and after the audit
Each row of dots is 32 men. Tap to switch between the comparison Leary published in 1965 and the comparison Doblin reconstructed in 1998. Figures rounded from the two papers.
To Leary's credit, when Doblin showed him the follow-up near the end of his life, he did not argue. He said the lesson was that psilocybin would need to be paired with the kind of post-release support that Alcoholics Anonymous provides, and that whether it would work "is an empirical question that deserves to be addressed within the context of a new experiment."4 That is a scientist's sentence. It came thirty years late.
The other famous study was the Good Friday experiment, run by Leary's graduate student Walter Pahnke in 1962: twenty divinity students in a chapel, half given psilocybin and half a placebo, to see whether the drug produced mystical experience.17 It did, and the finding has held up: in 2006 a double-blind study at Johns Hopkins, run with every safeguard Harvard lacked, found much the same thing, which is as close to vindication as an open-label study ever gets.6 But the published account left out that one subject became so agitated he had to be given a tranquilizer, and that the blind was broken within an hour.5 Omitting the adverse event is the part I cannot forgive, because adverse events are the whole point of a trial. I wrote about what happens to an adverse event in a modern study; in 1962 the answer was that it disappeared.
Harvard dismissed Leary and Richard Alpert in May 1963. The official reason was that Leary had left campus without permission and missed his classes.18 The underlying complaints had been aired at a faculty meeting a year earlier and reported in the student paper: that graduate students felt pressure to take part, that the experimenters took the drug with their subjects, that the studies had no controls, and, the thing that finally forced the issue, that the drug had reached undergraduates after the department had agreed it would not.1912 How much of that is "established"? The self-dosing is beyond dispute; Leary wrote it into his methods and defended it for the rest of his life. The undergraduate episode is documented and was the stated ground for Alpert's dismissal. The pressure on graduate students is the testimony of colleagues, which Leary disputed. I would not call the man a fraud; I would say he believed so completely that he stopped designing studies that could prove him wrong. When people say he "got psychedelic research banned," this is the first thing they should mean: not the slogan, but that the most visible psychedelic research in the country was being run in a way its own university could not defend. It gave everyone who wanted the research stopped an unanswerable reason.
Separate the person who gives the drug from the person who rates the outcome. Do not take the drug with your subjects. Do not study your own students. Compare against a control measured the same way over the same time. Record what went wrong even when it embarrasses you. Nearly every rule in a modern psychedelic protocol was written against a Harvard practice of 1961–63.1 And yet the questions those studies asked, whether a drug can occasion a religious experience, whether it can change a life the system has written off, whether the room and the guide matter as much as the molecule, are the questions the field is still answering, mostly in his favor. He did not have the answers. He had, for a while, a very good nose for the questions, and a method that could not catch him when he was wrong.
4The evangelist and the ban
After Harvard came the Millbrook estate, a sixty-four-room mansion in upstate New York lent by wealthy patrons, where Leary and his circle spent four years running what was variously called a research foundation, a religion and a party.11 He co-wrote The Psychedelic Experience there, a manual that cast the LSD session as a journey through the Tibetan Book of the Dead, which is the book that gave the Beatles "Tomorrow Never Knows" and gave a generation of users the idea that the experience had stages, that it could be guided, and that the guide mattered.20 That last part is sound. The rest is literature.
In May 1966 he testified before a Senate subcommittee and argued, in effect, for regulated access.21 By January 1967 he was on a stage in Golden Gate Park telling thirty thousand people to "turn on, tune in, drop out," and the argument was over.10 I should say that I like the slogan more than I am supposed to. Read as he later explained it, it is not bad advice: tune in to yourself; drop out of the conventions and norms you were handed without examining them, and find your own path. Half the therapy I practice is some version of that sentence. The trouble was never the sentence; it was thirty thousand people hearing it as a prescription, from a man with a Harvard title, with no setting and no guide. There is a sad irony in it too: the phrase became the mantra of the counterculture in its last loud year before the door closed, the final ruckus before prohibition, and the thing that was meant to open minds became the sound the lawmakers were reacting to. California had banned LSD the previous October; the federal government put LSD and psilocybin in Schedule I, no accepted medical use, in 1970.7 Legitimate research, which had produced over a thousand papers and treated tens of thousands of patients in the 1950s and 60s, dwindled to almost nothing for a quarter century.228
How much of that was Leary? Less than his critics say and more than his defenders admit. The backlash had many parents: Sandoz withdrawing the drug, the CIA's MK-Ultra experiments coming to light, the genuine casualties of unsupervised use, the war, the generation gap, Nixon, who reportedly called Leary "the most dangerous man in America."823 Prohibition would probably have come without him. But he gave it a face and a slogan, and he made every careful researcher's job impossible, because after 1967 to study LSD was to be asked about Timothy Leary. David Nichols, the pharmacologist who kept the chemistry alive through the dark years, has said as much; so has nearly everyone who did the work in the 1990s to bring the research back. The people with the most reason to be angry at him are the ones who agreed with him about the drug.
And yet. In the middle of the loudest period, in 1968, he wrote the sentence I think is the best thing he ever said, his "two commandments for the molecular age": Thou shalt not alter the consciousness of thy fellow man, and Thou shalt not prevent thy fellow man from altering his own consciousness.9 Consent in both directions. It is the principle under informed consent, under harm reduction, under the argument for regulated access, and under the argument against the thing he himself did at Harvard, where the first commandment was not followed with his students. He wrote the rule and broke it, which is a very human thing to do, and does not make the rule wrong.
5The outlaw years
The law caught up with him through marijuana, not LSD. Arrested at the Texas border in 1965 with a small amount of cannabis, he was sentenced to thirty years under the Marihuana Tax Act, a 1937 statute that required people to buy a tax stamp for a drug it was illegal to possess. He appealed, and in 1969 the Supreme Court agreed unanimously that the law forced self-incrimination and struck it down.24 That is a real civil-liberties victory with his name on it, and it is one reason the Controlled Substances Act of the next year was written the way it was.7
Then it got worse. A second arrest, a ten-year sentence in 1970, an escape over a prison wall arranged by the Weather Underground and paid for by LSD dealers, exile with Eldridge Cleaver in Algeria (who held him under house arrest), Switzerland, Afghanistan, capture, Folsom Prison and solitary confinement.1011 And then, in 1974, facing twenty-five years, he talked to the FBI. Records released in 1999 show he identified the people who had helped him escape; his son, Ram Dass and Allen Ginsberg denounced him publicly as an informant at the time.25 By the accounts I find most careful, nothing he said led to a charge, and he spent the rest of his life insisting he had given the government nothing it did not already have.2526 I am not going to litigate it. I will say that the man who wrote the two commandments knew exactly what he was weighing in that room, and that most of us, facing twenty-five years, do not know what we would do.
The cost that is easiest to overlook is the one closest to home. His first wife's death in 1955; his daughter Susan, who struggled for years and died by suicide in 1990; a son who denounced him and barely spoke to him. He wrote a great deal about expanding consciousness and very little about those three people, and I think the proportion tells you something.11
6The showman
The last twenty years were a performance, and some of it was a good one. He toured college campuses debating G. Gordon Liddy, the Watergate burglar who had once raided Millbrook as a county prosecutor, and the two of them seem to have become fond of each other.10 He decided the personal computer was the next psychedelic, which was half a joke and half a prophecy, and designed software nobody used. He produced an "eight-circuit model of consciousness" and an acronym, SMI²LE, for space migration, intelligence increase and life extension, which is not science and did not pretend very hard to be.27 When he was diagnosed with inoperable prostate cancer in 1995 he announced that he would die as a performance, called it "designer dying," considered having his head frozen, changed his mind, had the death filmed, and arranged for seven grams of his ashes to be launched into orbit, which they were, in 1997, on a rocket that also carried Gene Roddenberry.1028 His last words, by most accounts, were "why not?" and then "beautiful."
I find I cannot be angry at this part. A psychiatrist spends a lot of time with people who are terrified of dying, and here was a man who treated it as the last interesting experiment. He had, in the end, one unarguable gift, which was that he was not afraid, and he was funny, and those two things together got him through rooms that would have destroyed most of us. They also got him into them.
7What I keep, and what I don't
Set and setting. The single most useful sentence in the field, and he wrote it. Every dosing room I have ever set up is an argument that he was right.
The person's own authority. He insisted the experience belonged to the experiencer, not the doctor. The modern model of non-directive support is this idea with better manners.
The two commandments. Consent in both directions. Still the right frame.
The circle. A real, lasting piece of psychology, made before any of this.
The honesty of 1955 and 1996. Publishing that therapy did not work; conceding that Concord could not show it had. The instinct was there at the start and came back at the end.
The questions. Mystical experience, the prison, the guide and the room: open-label hunches that controlled trials have since largely borne out.
The humor, and the lack of fear.
The methods. Open-label results reported as proof, dosing with subjects by design, the drug reaching students, an adverse event left out. Colleagues objected at the time, not just in hindsight.
The evangelism. A drug that helps some people under careful conditions is not a sacrament for everyone, and saying so from a stage cost the field thirty years and cost some people more than that.
The data. Concord was overstated and was repeated for decades as if it were proven. The field is still living down claims like it.
The informant. Whatever the mitigation, the rule he wrote did not survive contact with a long sentence.
The family. He wrote a hundred thousand words about consciousness and almost none about his daughter.
If you work in this field now, the practical lesson is not "be unlike Leary." It is that the failure mode is available to anyone, and it is a slow one. He did not wake up a prophet. He had a transformative experience, found that it helped some people, began to believe it would help everyone, stopped designing studies that could prove him wrong, started preaching, and was carried by an audience that wanted him to. The sequence is visible in the modern field too, in miniature, every time a promising phase 2 result turns into a keynote. The antidote is the thing he did in 1955 and forgot in 1962: measure it, and publish when it comes out wrong.
8The ledger
I have given you my weighing. Here is a way to do your own. Nothing is stored.
Weigh him yourself
Slide each item toward "counts a lot" or "counts a little." The scale at the bottom is the sum. There is no right answer; the point is to notice which items move you.
Happy birthday, Dr. Leary. The research you wanted is happening, carefully, with the rules you taught us by breaking them. I think you would find that funny, and I think you would want to know the numbers.
A note on sources. The biographical sequence follows Greenfield's 2006 biography and Lattin's 2010 account, cross-checked against primary documents where they exist (the Supreme Court opinion, the 1965 Concord paper, Doblin's two follow-ups, the FBI records as reported in 1999). Leary's own memoir, Flashbacks, is a lively and unreliable source and is cited only for his own statements about himself.2611 Nothing here is medical advice, and nothing here is an endorsement of using psychedelics outside a lawful, supervised setting.
References
- US Food and Drug Administration. Psychedelic Drugs: Considerations for Clinical Investigations. Guidance for industry, final, July 2026.
- Leary T. Interpersonal Diagnosis of Personality: A Functional Theory and Methodology for Personality Evaluation. Ronald Press; 1957.
- Barron F, Leary TF. Changes in psychoneurotic patients with and without psychotherapy. J Consult Psychol. 1955;19(4):239–245.
- Doblin R. Dr. Leary's Concord Prison Experiment: a 34-year follow-up study. J Psychoactive Drugs. 1998;30(4):419–426. maps.org
- Doblin R. Pahnke's "Good Friday experiment": a long-term follow-up and methodological critique. J Transpersonal Psychol. 1991;23(1):1–28.
- Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. 2006;187:268–283. (The controlled replication of what the Good Friday experiment reported.)
- Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. 91-513 (the Controlled Substances Act), placing LSD and psilocybin in Schedule I.
- Nichols DE. Psychedelics. Pharmacol Rev. 2016;68(2):264–355.
- Leary T. The Politics of Ecstasy. Putnam; 1968. (Source of the "two commandments for the molecular age.")
- Timothy Leary. Wikipedia, accessed Oct 22, 2026, for dates and sequence of events; cross-checked against Greenfield 2006 and Lattin 2010 where they differ. en.wikipedia.org/wiki/Timothy_Leary
- Greenfield R. Timothy Leary: A Biography. Harcourt; 2006.
- Lattin D. The Harvard Psychedelic Club. HarperOne; 2010.
- Wiggins JS. A psychological taxonomy of trait-descriptive terms: the interpersonal domain. J Pers Soc Psychol. 1979;37(3):395–412. (The circumplex tradition that descends from Leary's 1957 model.)
- Hartogsohn I. Constructing drug effects: a history of set and setting. Drug Sci Policy Law. 2017;3:1–17.
- Zinberg NE. Drug, Set, and Setting: The Basis for Controlled Intoxicant Use. Yale University Press; 1984.
- Leary T, Metzner R, Presnell M, Weil G, Schwitzgebel R, Kinne S. A new behavior change program using psilocybin. Psychotherapy: Theory, Research and Practice. 1965;2(2):61–72. (The Concord Prison report.)
- Pahnke WN. Drugs and Mysticism: An Analysis of the Relationship Between Psychedelic Drugs and the Mystical Consciousness. PhD thesis, Harvard University; 1963. (The Good Friday / Marsh Chapel experiment.)
- Harvard University. Statement of President Nathan M. Pusey on the dismissal of Timothy Leary and Richard Alpert, May 27, 1963; reported in The Harvard Crimson, May 28, 1963.
- The Harvard Crimson. Psychologists disagree on psilocybin research (March 15, 1962); Leary, Alpert dismissed (May 28, 1963). Contemporary reporting of the faculty meeting, the agreement not to give the drug to undergraduates, and the dismissals.
- Leary T, Metzner R, Alpert R. The Psychedelic Experience: A Manual Based on the Tibetan Book of the Dead. University Books; 1964.
- US Senate, Subcommittee to Investigate Juvenile Delinquency (Dodd hearings). Organization and Coordination of Federal Drug Research and Regulatory Programs: LSD. May 1966. (Leary's testimony.)
- Grinspoon L, Bakalar JB. Psychedelic Drugs Reconsidered. Basic Books; 1979.
- Pollan M. How to Change Your Mind. Penguin Press; 2018.
- Leary v. United States, 395 U.S. 6 (1969). law.cornell.edu
- Associated Press. LSD guru Timothy Leary cooperated with FBI, records show. Seattle Times, July 1, 1999. archive.seattletimes.com
- Leary T. Flashbacks: An Autobiography. Tarcher; 1983.
- Leary T. Exo-Psychology. Starseed/Peace Press; 1977. (The eight-circuit model and SMI²LE.)
- Celestis, Inc. Founders Flight, April 21, 1997: a Pegasus rocket carried symbolic portions of the remains of Timothy Leary, Gene Roddenberry and others into orbit.